Oct 28, 2025 6:30 AM Eastern Daylight Time GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights Share GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third quarter of 2025. "GeneDx's accelerated growth reflects more than business momentum - it's proof of the profound impact we're making for families navigating rare disease and the broader tran ...